Relationship between low serum immunoglobulin E levels and malignancies in 9/11 World Trade Center responders.
-
2022/12/01
-
File Language:
English
Details
-
Personal Author:
-
Description:Background: Individuals with very low immunoglobulin E (IgE) levels have a high risk of developing malignancy. Previous studies have revealed that World Trade Center (WTC) responders exposed to carcinogens have an elevated risk of some cancers. Objective: To evaluate the association between low-serum IgE levels and cancer development in WTC-exposed responders. Methods: IgE levels were measured in 1851 WTC responders after September 11, 2001. This is the first pilot study in humans comparing the odds of developing cancer in this high-risk population, between the "low-IgE" (IgE in the lowest third percentile) vs "non-low-IgE" participants. Results: A significantly higher proportion of hematologic malignancies was found in low-IgE (4/55, 7.3%) compared with non-low-IgE (26/1796, 1.5%, P < .01) responders. The proportion of solid tumors were similar in both groups (5.5% vs 11.4%, P > .05). After adjustment for relevant confounders (race, sex, age at blood draw, WTC arrival time, smoking status), the low-IgE participants had 7.81 times greater odds (95% confidence interval, 1.77-29.35) of developing hematologic cancer when compared with non-low-IgE participants. The hematologic cancers found in this cohort were leukemia (n = 1), multiple myeloma (n = 1), and lymphoma (n = 2). No statistical significance was found when estimating the odds ratio for solid tumors in relation to IgE levels. Conclusion: WTC responders with low serum IgE levels had the highest odds of developing hematologic malignancies. This hypothesis-generating study suggests that low serum IgE levels might be associated with the development of specific malignancies in at-risk individuals exposed to carcinogens. Larger, multicenter studies with adequate follow-up of individuals with different IgE levels are needed to better evaluate this relationship. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1081-1206
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:129
-
Issue:6
-
NIOSHTIC Number:nn:20065725
-
Citation:Ann Allergy Asthma Immunol 2022 Dec; 129(6):769-775
-
Contact Point Address:Denisa Ferastraoaru, MD, Associate Professor of Internal Medicine/Allergy-Immunology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
-
Email:dferastr@montefiore.org
-
Federal Fiscal Year:2023
-
Performing Organization:New York City Fire Department
-
Peer Reviewed:True
-
Start Date:20140701
-
Source Full Name:Annals of Allergy, Asthma and Immunology
-
End Date:20170630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:9593e27015ce7bf06269051652ab0ca04c333c535dc30ecde09083c7841699f5ec4622d4baa32683c06d7a774c4f0d087de8eebf41132420bd9c6a2f644749be
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like